Provided that thirteen Member States Management ADB-CHMINACA below nationwide drug Management laws and four Member States Regulate ADB-CHMINACA under other laws, subjecting ADB-CHMINACA to control measures over the Union would enable steer clear of the emergence of hurdles in cross-border regulation enforcement and judicial cooperation, and w